Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Burmester
Pms5 - A Network Meta-Analysis to Evaluate the Efficacy of Baricitinib and Other Treatments of Rheumatoid Arthritis in Patients Who Are Inadequate Responders to Methotrexate
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
S2e-Leitlinie: Therapie Der Rheumatoiden Arthritis Mit Krankheitsmodifizierenden Medikamenten
Zeitschrift fur Rheumatologie
Rheumatology
Related publications
Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Longterm Safety, Efficacy, and Inhibition of Structural Damage Progression Over 5 Years of Treatment With Abatacept in Patients With Rheumatoid Arthritis in the Abatacept in Inadequate Responders to Methotrexate Trial
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Efficacy and Safety of Baricitinib for Active Rheumatoid Arthritis in Patients With an Inadequate Response to Conventional Synthetic or Biological Disease‑modifying Anti‑rheumatic Drugs: A Meta‑analysis of Randomized Controlled Trials
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
SAT0058 Effects of Baricitinib on Patients Who Stop Methotrexate Monotherapy and Switch to Baricitinib Monotherapy
Pms1 - Comparative Effectiveness of Baricitinib Versus Sarilumab in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
Advances in Therapy
Medicine
Pharmacology
Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Scientific Reports
Multidisciplinary
Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Efficacy of Tofacitinib Monotherapy in Methotrexate-Naive Patients With Early or Established Rheumatoid Arthritis
RMD Open
Rheumatology
Allergy
Immunology
